Betaseron - National Multiple Sclerosis Society

Skip to navigation Skip to content

Betaseron

Share

About this Medication
  • Brand Name: Betaseron® (U.S. and Canada)
  • Chemical Name: interferon (in-ter-feer-on) beta-1b
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

Betaseron® and Extavia® are taken by injection

 


Description

Betaseron® and Extavia® are brand names for interferon beta 1b, a medication manufactured by a biotechnological process from one of the naturally occurring interferons (a type of protein).

Betaseron and Extavia are approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing forms of MS to reduce the frequency of clinical exacerbations. Relapsing forms of MS include individuals with secondary-progressive MS who continue to experience relapses or acute attacks. Betaseron iand Extavia are also approved for use in individuals who have experienced a first clinical episode (clinically-isolated syndrome) and have MRI features that are consistent with multiple sclerosis.

Click here to read the FDA Prescribing Information for Betaseron.

Click here to read the FDA Medication Guide for patients.

Click here to read the FDA Prescribing Information for Extavia.

Click here to read the FDA Medication Guide for Extavia

Support

BETASERON SUPPORT PROGRAM
BETAPLUSTM
1-800-788-1467                                                                                                                                                                   www.betaseron.com/financial-support 
 

Financial Assistance Program

BETASERON PATIENT ASSISTANCE PROGRAM                                                                                                                          1-800-788-1467                                                                                                                                                                           www.betaseron.com/betaplus/affordability                                                                                                                                          

 



Share